PCVX
Vaxcyte Inc.
Company Overview
| Mkt Cap | $5.48B | Price | $45.28 |
| Volume | 1.39M | Change | +1.18% |
| P/E Ratio | -11.8 | Open | $44.30 |
| Revenue | -- | Prev Close | $44.75 |
| Net Income | $-463.9M | 52W Range | $27.66 - $116.00 |
| Div Yield | N/A | Target | $98.00 |
| Overall | 57 | Value | 60 |
| Quality | 47 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyVaxcyte Inc. (PCVX) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $45.28 with a market capitalization of $5.48 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows PCVX with a volume of 1.39 million shares. The stock opened down 1.01% from yesterday's close of $44.75. Current analyst estimates project earnings of $-5.19 per share for this year, with next year targeting $-5.82.
PCVX demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for PCVX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 116.4%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PCVX | $45.28 | +1.2% | 1.39M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |